· Intro
· Modelling
· VDSS
· Clearance
Definition: t1/2β |
· Time taken for plasma propofol concentration to fall by half during terminal elimination phase |
Equation |
· t1/2β = VDSS/Cl x loge2 |
Propofol’s numbers |
· Rapid clearance 30-60mL/kg/min · But very large volume of distribution 4L/kg · Hence long t1/2β 5-12 hours |
Significance |
· t1/2β rarely affects practice for anaesthetic agents · Very slow equilibration with vessel poor group · CSHT for propofol is only 50mins at 9 hours’ duration |
Compartment diagramme |
|
Washout curve |
|
Definition |
· Volume into which the drug appears to disperse |
Propofol |
· High lipid solubility confers · Rapid passage into CNS · Large VDSS 4L/kg |
↓VDSS -> ↓t1/2β |
· ↓Muscle mass (elderly, neonate, cachexia, anorexia) · ↓Fat mass (neonate, cachexia, anorexia) |
↑VDSS -> ↑t1/2β |
· ↑Muscle mass: athlete · ↑Fat mass (propofol lipophilic): obesity |
Definition |
· Volume of plasma from which drug is removed per unit time |
Propofol |
· Cl 30-60mL/kg/min · 99.7% metabolized · Liver plus ?lung ? kidney ? other (since hepatic blood flow 20mL/kg/min) · Phase 1 (3A4, 2B6, 2C19) and 2 (glucuronidation, sulfation) · Inactive metabolites · High hepatic extraction ratio 0.9 |
↓Cl |
· ↓Hepatic blood flow (high hepatic extraction ratio hence flow-limited clearance) o Shock o LV failure o Critical illness o Hypothermia o Elderly o Cirrhosis o ↓Enzymatic activity (must be very severe) · Liver failure o Enzyme inhibition |
↑Cl |
· ↑Hepatic blood flow e.g. pregnancy · ↑Enzymatic activity e.g. induction (makes minimal difference, extraction ratio 0.9) |
Feedback welcome at ketaminenightmares@gmail.com